Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hameln rds is a specialized contract research and development organization (CRO) based in Slovakia, serving as a key member of the hameln group. The company focuses on the development of parenteral drug products, offering services that span from initial formulation and analytical method development to stability studies and the production of clinical trial materials. With a strong emphasis on complex injectables and small molecules, Hameln rds supports pharmaceutical clients in navigating the technical and regulatory challenges of bringing new therapies to market. Their facilities are GMP-certified, ensuring high-quality standards for both human and veterinary medicinal products. They provide comprehensive support for the preparation of regulatory dossiers for global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hameln rds.